Cited by 26

The Correlation of Swedish Snus, Nicotine Pouches and Other Tobacco Products with Oral Mucosal Health and Salivary Biomarkers

Miluna, Sintija, Melderis, Ricards, Briuka, Loreta, Skadins, Ingus, Broks, Renars, Kroica, Juta, Rostoka, Dagnija·2022·Dentistry Journal

Abstract

In society, tobacco products, such as e-cigarettes, and smokeless tobacco products, such as snus and nicotine pouches, are becoming more attractive. There is still a lack of information regarding the effects of these products on the oral mucosa and oral saliva biomarkers. The aim of this study is to evaluate oral mucosa and the presence of inflammatory biomarkers IL-6, IL-1, IL-8, TNF alpha and LRG-1 in saliva. Respondents were divided in four groups based on their tobacco product usage. Oral examination was carried out, saliva samples were taken, and the detection of IL-6, IL-8, IL-1, TNF alpha and LRG-1 levels in saliva was carried out. Out of the tobacco users, 30.8% were snus users, 48.7% were cigarette users and 20.5% were e-cigarette users. The control group was composed of respondents who did not use any tobacco products. E-cigarettes were used more by women, but snus was used more by men. Mucosal changes were seen in the group of snus users, and mucosal changes were only seen in men who had used 5–10 tobacco units per day for 5–10 years. Increased IL-6 levels in saliva were detected in respondents who also experienced mucosal changes. Mucosal changes were white, leathery and localized at the site where snus sachets were placed. Saliva, as an easily available biofluid, could be used as a first tool to detect potentially precancerous signs, but the LRG1 marker cannot be used as a prognostic marker.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/dj10080154

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. [2]Clarke E. Thompson K. Weaver S. Thompson J. O’Connell G. Snus: A compelling harm reduction alternative to cigarettes Harm Reduct. J. 2019 16 62 10.1186/s12954-019-0335-1 31775744 PMC6882181 · DOI · Paper page
  2. [5]Mattioli A.V. Sciomer S. Cocchi C. Maffei S. Gallina S. Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease Nutr. Metab. Cardiovasc. Dis. 2020 30 1409 1417 10.1016/j.numecd.2020.05.020 32571612 PMC7260516 · DOI · Paper page
  3. [6]Mündel T. Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations Sports Med. 2017 47 2497 2506 10.1007/s40279-017-0764-5 28791650 PMC5684328 · DOI
  4. [7]Zandonai T. Chiamulera C. Mancabelli A. Falconieri D. Diana M. A Preliminary Investigation on Smokeless Tobacco Use and Its Cognitive Effects Among Athletes Front. Pharmacol. 2018 9 216 10.3389/fphar.2018.00216 29593541 PMC5857588 · DOI
  5. [10]Vogel E.A. Barrington-Trimis J.L. Kechter A. Tackett A.P. Liu F. Sussman S. Lerman C. Unger J.B. Hughes Halbert C. Chaffee B.W. Differences in Young Adults’ Perceptions of and Willingness to Use Nicotine Pouches by Tobacco Use Status Int. J. Environ. Res. Public Health 2022 19 2685 10.3390/ijerph19052685 35270385 PMC8910652 · DOI
  6. [11]Müller S. Frictional Keratosis, Contact Keratosis and Smokeless Tobacco Keratosis: Features of Reactive White Lesions of the Oral Mucosa Head Neck Pathol. 2019 13 16 24 10.1007/s12105-018-0986-3 30671762 PMC6405791 · DOI
  7. [12]Greer R.O. Oral Manifestations of Smokeless Tobacco Use Otolaryngol. Clin. N. Am. 2011 44 31 56 10.1016/j.otc.2010.09.002 21093622 · DOI
  8. [13]Mehrotra R. Yadav A. Sinha D.N. Parascandola M. John R.M. Ayo-Yusuf O. Nargis N. Hatsukami D.K. Warnakulasuriya S. Straif K. Smokeless tobacco control in 180 countries across the globe: Call to action for full implementation of WHO FCTC measures Lancet Oncol. 2019 20 e208 e217 10.1016/S1470-2045(19)30084-1 30942182 · DOI
  9. [14]Španko M. Strnadová K. Pavlíček A.J. Szabo P. Kodet O. Valach J. Dvořánková B. Smetana K. Jr. Lacina L. IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives Int. J. Mol. Sci. 2021 22 11027 10.3390/ijms222011027 34681685 PMC8540903 · DOI
  10. [15]Ferrari E. Pezzi M.E. Cassi D. Pertinhez T.A. Spisni A. Meleti M. Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review Int. J. Mol. Sci. 2021 22 6795 10.3390/ijms22136795 34202728 PMC8267678 · DOI
  11. [16]Chiamulera M.M.A. Zancan C.B. Remor A.P. Cordeiro M.F. Gleber-Netto F.O. Baptistella A.R. Salivary cytokines as biomarkers of oral cancer: A systematic review and meta-analysis BMC Cancer 2021 21 205 10.1186/s12885-021-07932-3 33639868 PMC7912500 · DOI
  12. [17]Sharma M. Bairy I. Pai K. Satyamoorthy K. Prasad S. Berkovitz B. Radhakrishnan R. Salivary IL-6 levels in oral leukoplakia with dysplasia and its clinical relevance to tobacco habits and periodontitis Clin. Oral Investig. 2010 15 705 714 10.1007/s00784-010-0435-5 20563615 · DOI
  13. [18]Babiuch K. Kuśnierz-Cabala B. Kęsek B. Okoń K. Darczuk D. Chomyszyn-Gajewska M. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders J. Clin. Med. 2020 9 867 10.3390/jcm9030867 PMC7141524 32245251 · DOI
  14. [19]Chang S.C. Lin W.L. Chang Y.F. Lee C.T. Wu J.S. Hsu P.H. Chang C.F. Glycoproteomic identification of novel plasma biomarkers for oral cancer J. Food Drug Anal. 2019 27 483 493 10.1016/j.jfda.2018.12.008 30987719 PMC9296197 · DOI
  15. [20]Khan S.Z. Farooq A. Masood M. Shahid A. Khan I.U. Nisar H. Fatima I. Smokeless tobacco use and risk of oral cavity cancer Turk. J. Med. Sci. 2020 50 291 297 10.3906/sag-1809-11 31655504 PMC7165244 · DOI
  16. [21]Gupta B. Johnson N.W. Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific PLoS ONE 2014 9 e113385 10.1371/journal.pone.0113385 25411778 PMC4239077 · DOI
  17. [22]Donald P.M. Renjith G. Arora A. Tobacco Pouch Keratosis in a young individual: A brief description J. Indian Soc. Periodontol. 2017 21 249 251 10.4103/jisp.jisp_109_17 29440796 PMC5803885 · DOI
  18. [23]Mu G. Wang J. Liu Z. Zhang H. Zhou S. Xiang Q. Cui Y. Association between smokeless tobacco use and oral cavity cancer risk in women compared with men: A systematic review and meta-analysis BMC Cancer 2021 21 960 10.1186/s12885-021-08691-x 34452595 PMC8394164 · DOI
  19. [24]Smyth E.M. Kulkarni P. Claye E. Stanfill S. Tyx R. Maddox C. Mongodin E.F. Sapkota A.R. Smokeless tobacco products harbor diverse bacterial microbiota that differ across products and brands Appl. Microbiol. Biotechnol. 2017 101 5391 5403 10.1007/s00253-017-8282-9 28432442 PMC5520664 · DOI
  20. [25]Fadus M.C. Smith T.T. Squeglia L.M. The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects Drug Alcohol Depend. 2019 201 85 93 10.1016/j.drugalcdep.2019.04.011 31200279 PMC7183384 · DOI
  21. [28]Sahibzada H.A. Khurshid Z. Khan R.S. Naseem M. Siddique K.M. Mali M. Zafar M.S. Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer Diagnostics 2017 7 21 10.3390/diagnostics7020021 28397778 PMC5489941 · DOI
  22. [29]Kaur J. Jacobs R. Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis J. Korean Assoc. Oral Maxillofac. Surg. 2015 41 171 175 10.5125/jkaoms.2015.41.4.171 26339574 PMC4558184 · DOI
  23. [30]Chang J.T. Vivar J.C. Tam J. Hammad H.T. Christensen C.H. van Bemmel D.M. Das B. Danilenko U. Chang C.M. Biomarkers of Potential Harm among Adult Cigarette and Smokeless Tobacco Users in the PATH Study Wave 1 (2013–2014): A Cross-sectional Analysis Cancer Epidemiol. Biomark. Prev. 2021 30 1320 1327 10.1158/1055-9965.EPI-20-1544 33947655 PMC8254764 · DOI
  24. [31]Nijakowski K. Gruszczyński D. Kopała D. Surdacka A. Salivary Metabolomics for Oral Squamous Cell Carcinoma Diagnosis: A Systematic Review Metabolites 2022 12 294 10.3390/metabo12040294 35448481 PMC9029144 · DOI
  25. [32]Kawahara R. Bollinger J.G. Rivera C. Ribeiro A.C. Brandão T.B. Paes Leme A.F. MacCoss M.J. A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva Proteomics 2016 16 159 173 10.1002/pmic.201500224 26552850 PMC4703492 · DOI
  26. [34]Azzopardi D. Liu C. Murphy J. Chemical characterization of tobacco-free “modern” oral nicotine pouches and their position on the toxicant and risk continuums Drug Chem. Toxicol. 2021 1 9 10.1080/01480545.2021.1925691 34034614 · DOI · Paper page

Authors
Miluna, S., Melderis, R., Briuka, L., Skadins, I., Broks, R., Kroica, J., & Rostoka, D.
Venue
Dentistry Journal
Publisher
MDPI AG
Published
2022-08-17
Volume
10
Issue
8
Pages
154
ISSN
2304-6767
Cited by
26
References
2
Language
en
Funders
European Social Fund and Latvian state budge (8.2.2.0/20/l/004)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review